Recent Advances in Microfluidic Chip Technology for Laboratory Medicine: Innovations and Artificial Intelligence Integration
Biosensors · 05.02.2026 · 16 (2) · 104
DOI: 10.3390/bios16020104 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 05.02.2026. Verfasst von Hong Cai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Hospital of Dalian Medical University, Dalian 116023, China. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dalian Science and Technology Innovation Fund Program, United Foundation for Dalian Institute of Chemical Physics, Chinese Academy of Sciences and the Second Hospital of Dalian Medical University, Dalian Life and Health Field Guidance Program Project.
Abstract (Originalsprache)
Microfluidic chip technologies, also known as lab-on-a-chip systems, have profoundly transformed laboratory medicine by enabling the miniaturization, automation, and rapid processing of complex diagnostic assays using minimal sample volumes. Recent advances in chip design, fabrication methods—including 3D printing, modular and flexible substrates—and biosensor integration have significantly enhanced the performance, sensitivity, and clinical applicability of these devices. Integration of advanced biosensors allows for real-time detection of circulating tumor cells, nucleic acids, and exosomes, supporting innovative applications in cancer diagnostics, infectious disease detection, point-of-care testing (POCT), personalized medicine, and therapeutic monitoring. Notably, the convergence of microfluidics with artificial intelligence (AI) and machine learning has amplified device automation, reliability, and analytical power, resulting in “smart” diagnostic platforms capable of self-optimization, automated analysis, and clinical decision support. Emerging applications in fields such as neuroscience diagnostics and microbiome profiling further highlight the broad potential of microfluidic technology. Here, we present findings from a comprehensive review of recent innovations in microfluidic chip design and fabrication, advances in biosensor and AI integration, and their clinical applications in laboratory medicine. We also discuss current challenges in manufacturing, clinical validation, and system integration, as well as future directions for translating next-generation microfluidic technologies into routine clinical and public health practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Second Hospital of Dalian Medical University, Dalian 116023, China.
ORCID-Profile: Hong Cai, Dongxia Wang, Yiqun Zhao, Chunhui Yang
Förderung
- Dalian Science and Technology Innovation Fund Program
- United Foundation for Dalian Institute of Chemical Physics, Chinese Academy of Sciences and the Second Hospital of Dalian Medical University
- Dalian Life and Health Field Guidance Program Project
- Liaoning Provincial Science and Technology Plan Joint Program Project
Zitieren
APA
Cai, H., Wang, D., Zhao, Y., & Yang, C. (2026). Recent Advances in Microfluidic Chip Technology for Laboratory Medicine: Innovations and Artificial Intelligence Integration. Biosensors, 16(2), 104. https://doi.org/10.3390/bios16020104
Vancouver
Cai H, Wang D, Zhao Y, Yang C. Recent Advances in Microfluidic Chip Technology for Laboratory Medicine: Innovations and Artificial Intelligence Integration. Biosensors. 2026;16(2):104. doi:10.3390/bios16020104
BibTeX
@article{Cai2026,
author = {Cai, Hong and Wang, Dongxia and Zhao, Yiqun and Yang, Chunhui},
title = {Recent Advances in Microfluidic Chip Technology for Laboratory Medicine: Innovations and Artificial Intelligence Integration},
journal = {Biosensors},
year = {2026},
volume = {16},
number = {2},
pages = {104},
doi = {10.3390/bios16020104}
}
EUVIMED